Clik here to view.
Participation d’ERYTECH à la prochaine conférence investisseurs ‘Morgan...
Tuesday, September 12th 2017 at 5:30am UTC LYON, France–(BUSINESS WIRE)– Regulatory News: ERYTECH Pharma (Paris:ERYP) (ADR: EYRYY) (Euronext Paris : ERYP), société biopharmaceutique de stade clinique...
View ArticleClik here to view.
Inotek Pharmaceuticals Announces Merger Agreement with Rocket Pharmaceuticals...
Tuesday, September 12th 2017 at 8:15pm UTC – Company to Leverage Lentiviral and AAV Gene Therapy Platforms to Target Rare Genetic Diseases – – Transaction to Advance Rocket’s Growing Pipeline; Up to...
View ArticleClik here to view.
DKMS Teams Up with FNTSY Sports Network to Save More Lives
Monday, September 11th 2017 at 2:54pm UTC Lifesaving nonprofit targets fantasy sports enthusiasts in strategic brand partnership NEW YORK–(BUSINESS WIRE)– As the 2017 NFL season gets underway, fantasy...
View ArticleClik here to view.
INSERTING and REPLACING Inotek Pharmaceuticals Announces Merger Agreement...
Tuesday, September 12th 2017 at 10:06pm UTC – Company to Leverage Lentiviral and AAV Gene Therapy Platforms to Target Rare Genetic Diseases – – Transaction to Advance Rocket’s Growing Pipeline; Up to...
View ArticleClik here to view.
Alpine Immune Sciences to Present at Ladenburg Thalmann 2017 Healthcare...
Wednesday, September 13th 2017 at 8:05pm UTC SEATTLE–(BUSINESS WIRE)– Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading immunotherapy company focused on the development of treatments for...
View ArticleClik here to view.
Lantheus Holdings, Inc. to Present at 2017 Cantor Fitzgerald Global...
Wednesday, September 13th 2017 at 8:02pm UTC NORTH BILLERICA, Mass.–(BUSINESS WIRE)– Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc....
View ArticleClik here to view.
22nd Century to Speak at Global Tobacco & Nicotine Forum
Wednesday, September 13th 2017 at 1:55pm UTC CLARENCE, N.Y.–(BUSINESS WIRE)– 22nd Century Group, Inc. (NYSE American:XXII), a plant biotechnology company that is focused on tobacco harm reduction,...
View ArticleClik here to view.
Bristol-Myers Squibb Announces Dividend
Wednesday, September 13th 2017 at 8:30pm UTC NEW YORK–(BUSINESS WIRE)– The Board of Directors of Bristol-Myers Squibb Company (NYSE:BMY) today declared a quarterly dividend of thirty-nine cents...
View ArticleClik here to view.
PURE Bioscience to Present at 2017 SeeThru Equity Investor Conference
Thursday, September 14th 2017 at 12:36pm UTC SAN DIEGO–(BUSINESS WIRE)– PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today...
View ArticleClik here to view.
Arrowhead Hosts Investor & Analyst R&D Day to Introduce TRiM™ Platform and...
Thursday, September 14th 2017 at 4:00pm UTC PASADENA, Calif.–(BUSINESS WIRE)– Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR), is hosting an investor & analyst R&D day in New York today to...
View ArticleClik here to view.
Pfizer and Astellas Announce Positive Top-Line Results from Phase 3 PROSPER...
Thursday, September 14th 2017 at 9:00am UTC Enzalutamide is the first androgen receptor-inhibitor to demonstrate a statistically significant improvement in metastasis-free survival (MFS) in this...
View ArticleClik here to view.
Imara Reports Favorable Preclinical and Phase 1 Data on IMR-687 in Sickle...
Thursday, September 14th 2017 at 12:00pm UTC Preclinical data demonstrates IMR-687 reduces white cell pathologies associated with the disease Phase 1 clinical study demonstrates once-daily, oral...
View ArticleClik here to view.
Bristol-Myers Squibb Names Karen Vousden, Ph.D. to Board of Directors
Wednesday, September 13th 2017 at 8:15pm UTC NEW YORK–(BUSINESS WIRE)– Bristol-Myers Squibb Company (NYSE:BMY) today announced that its Board of Directors has elected Karen Vousden, Ph.D., to the...
View ArticleClik here to view.
Acorda to Present at the Cantor Fitzgerald Global Healthcare Conference
Wednesday, September 13th 2017 at 11:00am UTC ARDSLEY, N.Y.–(BUSINESS WIRE)– Acorda Therapeutics, Inc. (Nasdaq:ACOR) announced that Ron Cohen, M.D., Acorda’s President and CEO, will present at the...
View ArticleClik here to view.
Klick Health Named 2017 Agency of the Year by PM360
Friday, September 15th 2017 at 5:04pm UTC TORONTO & NEW YORK–(BUSINESS WIRE)– Klick Health won the 2017 Advertising Agency of the Year Gold Award last night at the PM360 Trailblazer Awards – an...
View ArticleClik here to view.
JDRF Funds Zucara Therapeutics’ Approach to Preventing Hypoglycemia in People...
Thursday, September 21st 2017 at 1:00pm UTC NEW YORK & TORONTO–(BUSINESS WIRE)– As Global Biotech Week begins in more than 20 countries, JDRF, the leading organization funding type 1 diabetes...
View ArticleClik here to view.
ACADIA Pharmaceuticals to Present at the Ladenburg Thalmann 2017 Healthcare...
Tuesday, September 19th 2017 at 1:00pm UTC SAN DIEGO–(BUSINESS WIRE)– ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of...
View ArticleClik here to view.
Bristol-Myers Squibb to Take Part in Leerink Partners Rare Disease &...
Thursday, September 21st 2017 at 10:59am UTC NEW YORK–(BUSINESS WIRE)– Bristol-Myers Squibb Company (NYSE:BMY) will take part in Leerink Partners Rare Disease & Immuno-Oncology Roundtable...
View ArticleClik here to view.
Applied DNA Sciences to Present at the 2017 Disruptive Growth Company...
Thursday, September 21st 2017 at 9:30am UTC STONY BROOK, N.Y.–(BUSINESS WIRE)– Applied DNA Sciences, Inc. (NASDAQ: APDN), announced that Dr. James Hayward, president & CEO, will present at the...
View ArticleClik here to view.
Ignyta to Present at the Ladenburg Thalmann 2017 Healthcare Conference
Monday, September 18th 2017 at 11:00am UTC SAN DIEGO–(BUSINESS WIRE)– Ignyta, Inc. (Nasdaq:RXDX), a biotechnology company focused on precision medicine in oncology, announced today that Jonathan Lim,...
View Article